As Delta Plus Variant Identified, Changes To India’s Trials Policy Could Help

Serum/AZ COVID-19 Vaccine Interval Could Be Revised

 
• By Vibha Ravi
New Coronavirus variant outbreak and covid-19 virus cell mutation
Policy Flexibility Is The Need Of The Hour As Coronavirus Changes It Colors

More from Vaccines

More from Pink Sheet